Fecal Calprotectin Testing Can Identify Ineffective Colorectal Cancer Surveillance Procedures in Patients with Longstanding Colitis
Authors:
Open Access
- 1 April 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 20 (6) , 1079-1084
Abstract
Background. Active colitis impairs neoplasia detection during colonoscopic surveillance for colorectal cancer in patients with inflammatory bowel disease. We inKeywords
This publication has 23 references indexed in Scilit:
- European evidence based consensus for endoscopy in inflammatory bowel diseaseJournal of Crohn's and Colitis, 2013
- Declining Risk of Colorectal Cancer in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Incidence and Mortality of Colorectal Adenocarcinoma in Persons With Inflammatory Bowel Disease From 1998 to 2010Gastroenterology, 2012
- Misclassification of dysplasia in patients with inflammatory bowel diseaseInflammatory Bowel Diseases, 2011
- Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)Gut, 2010
- AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel DiseaseGastroenterology, 2010
- Chromoendoscopy-Targeted Biopsies Are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective Endoscopic TrialAmerican Journal of Gastroenterology, 2008
- Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitisGut, 2004
- Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitisGastroenterology, 2003
- Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applicationsHuman Pathology, 1983